BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19665071)

  • 1. Allelic loss of the PTEN gene and mutation of the TP53 gene in choriocarcinoma arising from gastric adenocarcinoma: analysis of loss of heterozygosity in two male patients with extragonadal choriocarcinoma.
    Tate G; Suzuki T; Nemoto H; Kishimoto K; Hibi K; Mitsuya T
    Cancer Genet Cytogenet; 2009 Sep; 193(2):104-8. PubMed ID: 19665071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of the KIT gene and loss of heterozygosity of the PTEN region in a primary malignant melanoma arising from a mature cystic teratoma of the ovary.
    Tate G; Tajiri T; Suzuki T; Mitsuya T
    Cancer Genet Cytogenet; 2009 Apr; 190(1):15-20. PubMed ID: 19264228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of loss of heterozygosity of encoding phosphate and tensin homolog on the prognosis of gastric cancer.
    Oki E; Kakeji Y; Baba H; Tokunaga E; Nakamura T; Ueda N; Futatsugi M; Yamamoto M; Ikebe M; Maehara Y
    J Gastroenterol Hepatol; 2006 May; 21(5):814-8. PubMed ID: 16704528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.
    Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC
    J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
    Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
    Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutations.
    Kolasa IK; Rembiszewska A; Janiec-Jankowska A; Dansonka-Mieszkowska A; Lewandowska AM; Konopka B; Kupryjańczyk J
    Gynecol Oncol; 2006 Nov; 103(2):692-7. PubMed ID: 16793127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic mutual relationship between PTEN and p53 in gastric cancer.
    Oki E; Tokunaga E; Nakamura T; Ueda N; Futatsugi M; Mashino K; Yamamoto M; Watanabe M; Ikebe M; Kakeji Y; Baba H; Maehara Y
    Cancer Lett; 2005 Sep; 227(1):33-8. PubMed ID: 16051030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biallelic inactivating mutations and an occult germline mutation of PTEN in primary cervical carcinomas.
    Kurose K; Zhou XP; Araki T; Eng C
    Genes Chromosomes Cancer; 2000 Oct; 29(2):166-72. PubMed ID: 10959096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity of PTEN (encoding phosphate and tensin homolog) associated with elevated HER2 expression is an adverse prognostic indicator in gastric cancer.
    Zaitsu Y; Oki E; Ando K; Ida S; Kimura Y; Saeki H; Morita M; Hirahashi M; Oda Y; Maehara Y
    Oncology; 2015; 88(3):189-94. PubMed ID: 25472613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity on 10q23.3 and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions.
    Li YL; Tian Z; Wu DY; Fu BY; Xin Y
    World J Gastroenterol; 2005 Jan; 11(2):285-8. PubMed ID: 15633233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity on chromosome 10q23 and mutation of the phosphatase and tensin homolog deleted from chromosome 10 tumor suppressor gene in Korean hepatocellular carcinoma patients.
    Bae JJ; Rho JW; Lee TJ; Yun SS; Kim HJ; Choi JH; Jeong D; Jang BC; Lee TY
    Oncol Rep; 2007 Oct; 18(4):1007-13. PubMed ID: 17786367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the PTEN tumor gene and risk of endometriosis: a case-control study.
    Govatati S; Kodati VL; Deenadayal M; Chakravarty B; Shivaji S; Bhanoori M
    Hum Reprod; 2014 Feb; 29(2):324-36. PubMed ID: 24154570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
    Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
    Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma.
    Kulke MH; Odze RD; Thakore KS; Thomas G; Wang H; Loda M; Eng C
    Br J Cancer; 2001 Mar; 84(6):748-53. PubMed ID: 11259087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance].
    Li JT; Fu L; Xia JC; Feng BJ; Mai SJ; Yu XJ; Huang LX; Feng QS; Pan ZZ; Zhan YQ
    Ai Zheng; 2005 Nov; 24(11):1306-11. PubMed ID: 16552953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
    Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
    Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant glioma: the involvement of loss of allelic heterozygosity and PTEN mutations in a group of Malay patients.
    Zainuddin N; Jaafar H; Isa MN; Abdullah JM
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):748-56. PubMed ID: 16124450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN mutation, loss of heterozygosity, promoter methylation and expression in colorectal carcinoma: two hits on the gene?
    Hühns M; Salem T; Schneider B; Krohn M; Linnebacher M; Prall F
    Oncol Rep; 2014 May; 31(5):2236-44. PubMed ID: 24647592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.
    Fujisawa H; Kurrer M; Reis RM; Yonekawa Y; Kleihues P; Ohgaki H
    Am J Pathol; 1999 Aug; 155(2):387-94. PubMed ID: 10433932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of PTEN and the 10q23 region in primary prostate carcinomas.
    Feilotter HE; Nagai MA; Boag AH; Eng C; Mulligan LM
    Oncogene; 1998 Apr; 16(13):1743-8. PubMed ID: 9582022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.